Big Gain For Sierra Oncology, Inc.

Sierra Oncology, Inc. (SRRA:NASDAQ) shot up at $0.5, representing a gain of 44.2%. On Fri 29 Nov 19, SRRA:NASDAQ hit a New 2-Week High of $0.35. The stock got featured on our News Catalysts scanner on Tue 26 Nov 19 at 07:37 AM in the 'PUBLIC OFFERING' category. From Fri 08 Nov 19, the stock recorded 42.86% Up Days and 20.00% Green Days

About Sierra Oncology, Inc. (SRRA:NASDAQ)

Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.